2International Federation of Clinical Chemistry and Laboratory Medicine,IFCC Scientific Division,Nordin G. Recommendation for term and measurement unit for "HbA1 c"[J].{H}Clinical Chemistry and Laboratory Medicine,2007,(08):1081-1082.
3Pradhan AD,Rifai N,Buring JE. Hemoglobin A1 c predicts diabetes but not cardiovascular disease in nondiabetic women[J].{H}American Journal of Medicine,2007,(08):720-727.
4Sarwar N,Aspelund T,Eiriksdottir G. Markers of dysglycaemia and risk of coronary heart disease in people without diabetes:Reykjavik prospective study and systematic review[J].{H}PLOS MEDICINE,2010,(05):e1000278.
5Kramer CK,von Mühleu D,Gross JL. Blood pressure and fasting plasma glucose rather than meta-bolic syndrome predict coronary artery calcium pro-gssion:the Rancho Bernardo Study[J].{H}DIABETES CARE,2009,(01):141-146.
6Voidonikola PT,Stamatelopoulos KS,Alevizaki M. The association between glycemia and endothelial function in nondiabetic individuals:the importance of body weight[J].Obesity (Silver Spring),2008,(12):2658-2662.
7Imanaka S. Epidemiological study on HbA1 c 1 evel below 6.1% among community residents and follow-up study of HbA1 c level-clinical significance of health ex-amination(Japan)in the aged members from the view point of glucose metabolism[J].Nihon Ronel Igakkai Zasshi,2011,(03):271-275.
1Goldstein DE, Little RR, Lorenz RA, et al. Tests of glycemia in diabetes. Diabetes Care, 2004, 27(7) :1761-1773.
2Schnedl WJ, Krause R, Halwachs,Baumann G, et al. Evaluation of HbAlc determination methods in patients with hemoglobinopathies. Diabetes Care, 2000, 23 (3) :339-344.
3Bry L, Chen PC, Sacks DB. Effects of hemoglobin variants and chemically modified derivatives on assays for glycohemoglobin. Clin Chem, 2001,47(2) :153-163.
4American Diabetes Association Clinical Practice Recommendations 2001. Diabetes Care, 2001, 24 ( Suppl 1 ) : S1- S133.
5American Diabetes Association. Standards of medical care in diabetes. Diabetes Care, 2004, 27 (Suppl 1) :S15-S35.
6Evers IM, de Valk HW, Mol BW, et al. Macrosomia despite good glycaemic control in Type Ⅰ diabetic pregnancy; results of a nation wide study in The Netherlands. Diabetologia, 2002, 45 ( 11 ) : 1484-1489.
7Kennedy DM, Johnson AB, Hill PG. A comparison of automated fructosamine and HbAlc methods for monitoring diabetes in pregnancy. Ann Clin Biochem, 1998, 35 (Pt 2) : 283 -289.
8Adler AI, Stratton IM, Neil HA, et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes ( UKPDS 36) : prospective observational study. BMJ, 2000, 321(7258) :412-419.
9Krishnamurti U, Steffes MW. Glycohemoglobin:a primary predictor of the development or reversal of complications of diabetes mellitus. Clin Chem, 2001,47 (7) : 1157-1165.
10Tominaga M. Diabetes mellitus and HbAlc. Rinsho Byori, 2003, 51(6) :586-591.
1Balducci S,Zanuso S,Cardelli P,et al.Supervised exercise training counterbalances the averse effects of insulin therapy in overweight/obese subjects with type 2 diabetes[J].Diabetes Care,2012,35(1):39-41.
2Singh N,Singh N,Kumar Singh S,et al.Reduced Antioxidant Potential of LDL Is Associated With Increased Susceptibility to LDL Peroxidation in Type II Diabetic Patients[J].Int J Endo- crinol Metab,2012,10(4):582-586.
3Ametov AS,Kochergina II,Ulanova KA.Effect of insulin therapy on insulin resistance and risk for ischemic heart disease and death from cardiovascular pathology in patients with diabe- tes mellitus,type 2[J].Ter Arkh,2010,82(3):42-46.
